Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Why Pfizer's Biggest Experimental Drug Got A Name Change.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • المؤلفون: Herper, Matthew
  • المصدر:
    Forbes.com. 3/2/2011, p49-49. 1p.
  • معلومة اضافية
    • الموضوع:
      PFIZER Inc.; ANTIRHEUMATIC agents; ANTI-inflammatory agents; ANALGESICS; DRUGS
    • نبذة مختصرة :
      The article reports that drug company Pfizer has changed the name of its JAK3 inhibitor for rheumatoid arthritis from tasocitinib to tofacitinib. According to the author, the company decided to change the name because tasocitinib sounds similar with other drug names, particularly with tazocilline and dacomitinib. He reports that this is not the first time that drug names have been changed. He adds that this shows the complicated regulations that drug companies need to go through.